Biolargo, Inc.
BLGO· OTC
BLGOBiolargo, Inc.
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001437749-26-017391
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $1.12M | $3.27M | $4.76M | $3.74M |
| Net Income | -$3.41M | -$1.92M | -$775.00K | -$494.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
